Contrary to what Federal Trade Commissioner Maureen Ohlhausen says, there is in fact no meaningful proof that consolidation generates social benefits.
Editor's note: In...
A new study suggests that “pay for delay” settlements–in which generic drug manufacturers that challenge the patents of branded drug firms agree to drop...
Concentration of power in supply chains is a prime mechanism by which dominant companies consolidate power and profits.
The Sherman Antitrust Act of 1890 was...
In an interview with ProMarket, antitrust lawyer Gary Reback elaborated on the difference between antitrust enforcement in the U.S. and Europe, the influence the U.S. Supreme...
Ten days after the White House issued an executive order and a brief that highlights growing concentration and decreasing competition in the US economy,...